ghk-cu scars for Keloid Research — Mechanism Evidence Scar results don't start at

In a randomized, double-blind trial where women applied GHK-Cu encapsulated in a nano-lipid carrier twice daily for 8 weeks, the treatment group saw significant improvements in wrinkle depth and volume with no serious adverse events

Complete degradation of the endocrine disruptor di-(2-ethylhexyl) phthalate by a novel Agromyces sp

How Epithalon fits into a broader supervised longevity peptide program Epithalon is a longevity-focused protocol

One published case series (N=14 patients, mixed athletic backgrounds) noted that 11 of 14 participants reported reduced DOMS duration from an average of 72 hours to approximately 36 hours, though this was self-reported and uncontrolled

Certificate of Analysis (COA) High-Performance Liquid Chromatography (HPLC) Mass Spectrometry (MS) References Pickart L et al